表紙
市場調查報告書

臨床腫瘤次世代定序的全球市場:COVID19下的成長與變化

Clinical Oncology Next Generation Sequencing Global Market Report 2020-30: COVID 19 Growth and Change

出版商 The Business Research Company 商品編碼 968171
出版日期 內容資訊 英文 200 Pages
商品交期: 2-3個工作天內
價格
臨床腫瘤次世代定序的全球市場:COVID19下的成長與變化 Clinical Oncology Next Generation Sequencing Global Market Report 2020-30: COVID 19 Growth and Change
出版日期: 2020年11月03日內容資訊: 英文 200 Pages
簡介

本報告提供全球臨床腫瘤次世代定序市場調查,市場特性,市場規模與成長性,各技術,各用途,各終端用戶,各地區,各國分析,競爭情形,企業簡介,合併和收購的動向,市場趨勢和策略等資訊。

目錄

第1章 摘要整理

第2章 市場特性

第3章 市場規模與成長性

  • 市場成果
    • 市場成長要素
    • 市場阻礙因素
  • 市場預測
    • 市場成長要素
    • 市場阻礙因素

第4章 市場區隔

  • 各技術的成果與預測
    • 離子半導體定序
    • 焦磷酸測序
    • 合成定序
    • 即時定序
    • 連接測序
    • 可逆確定序列
    • 奈米孔洞定序
  • 各用途的成果與預測
    • 篩檢
    • 搭配診斷
    • 其他診斷
  • 各終端用戶的成果與預測
    • 醫院內的檢驗室
    • 臨床檢驗組織
    • 診斷檢驗室

第5章 各地區,各國分析

  • 各地區的成果與預測
  • 各國成果與預測

第6章 亞太地區市場

  • 市場概要
  • 各技術的成果與預測
  • 各終端用戶的成果與預測

第7章 中國市場

第8章 印度市場

第9章 日本市場

第10章 澳洲市場

第11章 印尼市場

第12章 韓國市場

第13章 西歐市場

第14章 英國市場

第15章 德國市場

第16章 法國市場

第17章 東歐市場

第18章 俄羅斯市場

第19章 北美市場

第20章 美國市場

第21章 南美市場

第22章 巴西市場

第23章 中東市場

第24章 非洲市場

第25章 競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • Thermo Fisher Scientific(Qiagen)
    • Oxford Nanopore Technologies
    • QIAGEN
    • Myriad Genetics
    • Illumina

第26章 主要合併和收購

第27章 市場趨勢與策略

第28章 市場未來展望與成長性分析

第29章 附錄

目錄

Clinical Oncology Next Generation Sequencing Market Global Report 2020-30: Covid 19 Growth And Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global clinical oncology next generation sequencing market.

This report focuses on clinical oncology next generation sequencing market which is experiencing strong growth. The report gives a guide to the clinical oncology next generation sequencing market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the clinical oncology next generation sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Clinical Oncology Next Generation Sequencing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider clinical oncology next generation sequencing market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The clinical oncology next generation sequencing market section of the report gives context. It compares the clinical oncology next generation sequencing market with other segments of the clinical oncology next generation sequencing market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, clinical oncology next generation sequencing indicators comparison.

Scope

Markets Covered:

  • 1) By Technology: Ion Semiconductor Sequencing; Pyro-Sequencing; Synthesis Sequencing; Real Time Sequencing; Ligation Sequencing; Reversible Dye Termination Sequencing; Nano-Pore Sequencing
  • 2) By Application: Screening; Companion Diagnostics; Other Diagnostics
  • 3) By End User: Hospital Laboratories; Clinical Research Oraganizations; Diagnostic laboratories
  • Companies Mentioned: Thermo Fisher Scientific(Qiagen); Oxford Nanopore Technologies; QIAGEN; Myriad Genetics; Illumina
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Clinical Oncology Next Generation Sequencing Market Characteristics

3. Clinical Oncology Next Generation Sequencing Market Size And Growth

  • 3.1. Global Clinical Oncology Next Generation Sequencing Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Clinical Oncology Next Generation Sequencing Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Clinical Oncology Next Generation Sequencing Market Segmentation

  • 4.1. Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Ion Semiconductor Sequencing
  • Pyro-Sequencing
  • Synthesis Sequencing
  • Real Time Sequencing
  • Ligation Sequencing
  • Reversible Dye Termination Sequencing
  • Nano-Pore Sequencing
  • 4.2. Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Screening
  • Companion Diagnostics
  • Other Diagnostics
  • 4.3. Global Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Laboratories
  • Clinical Research Oraganizations
  • Diagnostic laboratories

5. Clinical Oncology Next Generation Sequencing Market Regional And Country Analysis

  • 5.1. Global Clinical Oncology Next Generation Sequencing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Clinical Oncology Next Generation Sequencing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Clinical Oncology Next Generation Sequencing Market

  • 6.1. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Overview
  • 6.2. Asia-Pacific Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Clinical Oncology Next Generation Sequencing Market

  • 7.1. China Clinical Oncology Next Generation Sequencing Market Overview
  • 7.2. China Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Clinical Oncology Next Generation Sequencing Market

  • 8.1. India Clinical Oncology Next Generation Sequencing Market Overview
  • 8.2. India Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Clinical Oncology Next Generation Sequencing Market

  • 9.1. Japan Clinical Oncology Next Generation Sequencing Market Overview
  • 9.2. Japan Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Clinical Oncology Next Generation Sequencing Market

  • 10.1. Australia Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Clinical Oncology Next Generation Sequencing Market

  • 11.1. Indonesia Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Clinical Oncology Next Generation Sequencing Market

  • 12.1. South Korea Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Clinical Oncology Next Generation Sequencing Market

  • 13.1. Western Europe Clinical Oncology Next Generation Sequencing Market Overview
  • 13.2. Western Europe Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Clinical Oncology Next Generation Sequencing Market

  • 14.1. UK Clinical Oncology Next Generation Sequencing Market Overview
  • 14.2. UK Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Clinical Oncology Next Generation Sequencing Market

  • 15.1. Germany Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Clinical Oncology Next Generation Sequencing Market

  • 16.4. France Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Clinical Oncology Next Generation Sequencing Market

  • 17.1. Eastern Europe Clinical Oncology Next Generation Sequencing Market Overview
  • 17.2. Eastern Europe Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Clinical Oncology Next Generation Sequencing Market

  • 18.1. Russia Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Clinical Oncology Next Generation Sequencing Market

  • 19.1. North America Clinical Oncology Next Generation Sequencing Market Overview
  • 19.2. North America Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Clinical Oncology Next Generation Sequencing Market

  • 20.1. USA Clinical Oncology Next Generation Sequencing Market Overview
  • 20.2. USA Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Clinical Oncology Next Generation Sequencing Market

  • 21.1. South America Clinical Oncology Next Generation Sequencing Market Overview
  • 21.2. South America Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Clinical Oncology Next Generation Sequencing Market

  • 22.1. Brazil Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Clinical Oncology Next Generation Sequencing Market

  • 23.1. Middle East Clinical Oncology Next Generation Sequencing Market Overview
  • 23.2. Middle East Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Clinical Oncology Next Generation Sequencing Market

  • 24.1. Africa Clinical Oncology Next Generation Sequencing Market Overview
  • 24.2. Africa Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Clinical Oncology Next Generation Sequencing Market Competitive Landscape And Company Profiles

  • 25.1. Clinical Oncology Next Generation Sequencing Market Competitive Landscape
  • 25.2. Clinical Oncology Next Generation Sequencing Market Company Profiles
    • 25.2.1. Thermo Fisher Scientific(Qiagen)
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Oxford Nanopore Technologies
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. QIAGEN
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Myriad Genetics
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Illumina
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Clinical Oncology Next Generation Sequencing Market

27. Clinical Oncology Next Generation Sequencing Market Trends And Strategies

28. Clinical Oncology Next Generation Sequencing Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer